National Institutes of Health Statement of Organization, Functions, and Delegations of Authority, 16393 [2015-07064]

Download as PDF 16393 Federal Register / Vol. 80, No. 59 / Friday, March 27, 2015 / Notices A contractor will also collect assault injury data from nursing home violent event reports three years pre-regulation (2009–2011) and three years postregulation (2012–2014). This data will be collected from existing OSHA logs; a NIOSH employee will fill out the Employee Incident Form from the OSHA logs received from the contractor. The purpose of collecting these data is to evaluate changes in assault injury rates before and after enactment of the regulations (Aim 2). The following information will be abstracted from the OSHA logs: Date, time and location of the incident; identity, job title and job task of the victim; identity of the perpetrator; description of the violent act, including whether a weapon was used; description of physical injuries; number of employees in the vicinity when the incident occurred, and their actions in response to the incident; recommendations of police advisors, employees or consultants, and; actions taken by the facility in response to the incident. No employee or perpetrator identifiable information will be collected. There are no costs to respondents other than their time. The total estimated burden hours are 120. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Average burden per esponse (in hours) Number of responses per respondent Total burden (in hours) Type of respondents Form name Nursing Home Administrator .................. Nursing Home Administrator .................. Nursing Home Administrator .................. Interview ...................................... Abstraction Form ......................... Employee Incident Form ............. 40 40 40 1 1 1 1 1 1 40 40 40 Total ................................................ ..................................................... ........................ ........................ ........................ 120 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. Dated: March 20, 2015. Francis S. Collins, Director, NIH. [FR Doc. 2015–07064 Filed 3–26–15; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2015–07038 Filed 3–26–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–0114] mstockstill on DSK4VPTVN1PROD with NOTICES National Institutes of Health Statement of Organization, Functions, and Delegations of Authority Part N, National Institutes of Health (NIH), of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (40 FR 22859, May 27, 1975, as amended most recently at 77 FR 1941, January 12, 2012, and redesignated from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as set forth below to rename the National Center for Complementary and Alternative Medicine (NCCAM). Section N–D, Organization and Functions, under the heading National Center for Complementary and Alternative Medicine (NCCAM), is renamed to the National Center for Complementary and Integrative Health (NCCIH). Delegations of Authority Statement: All delegations and redelegations of authority to officers and employees of NIH that were in effect immediately prior to the effective date of this reorganization and are consistent with this reorganization shall continue in effect, pending further redelegation. VerDate Sep<11>2014 20:59 Mar 26, 2015 Jkt 235001 Agency Information Collection Activities; Proposed Collection; Comment Request; Request for Samples and Protocols AGENCY: Food and Drug Administration, HHS. ACTION: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection requirements relating to the regulations which state that protocols for samples of biological products must be submitted to the Agency. DATES: Submit either electronic or written comments on the collection of information by May 26, 2015. Frm 00035 Fmt 4703 FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: Under the PRA (44 U.S.C. 3501–3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. SUPPLEMENTARY INFORMATION: Notice. SUMMARY: PO 00000 Submit electronic comments on the collection of information to https:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. ADDRESSES: Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 80, Number 59 (Friday, March 27, 2015)]
[Notices]
[Page 16393]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07064]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health Statement of Organization, 
Functions, and Delegations of Authority

    Part N, National Institutes of Health (NIH), of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (40 FR 22859, May 27, 1975, as 
amended most recently at 77 FR 1941, January 12, 2012, and redesignated 
from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as 
set forth below to rename the National Center for Complementary and 
Alternative Medicine (NCCAM).
    Section N-D, Organization and Functions, under the heading National 
Center for Complementary and Alternative Medicine (NCCAM), is renamed 
to the National Center for Complementary and Integrative Health 
(NCCIH).
    Delegations of Authority Statement: All delegations and 
redelegations of authority to officers and employees of NIH that were 
in effect immediately prior to the effective date of this 
reorganization and are consistent with this reorganization shall 
continue in effect, pending further redelegation.

    Dated: March 20, 2015.
Francis S. Collins,
Director, NIH.
[FR Doc. 2015-07064 Filed 3-26-15; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.